| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |